Biofrontera Inc. Fair Value Adjustment of Warrants
Biofrontera Inc. (BFRI) reported Fair Value Adjustment of Warrants of -$44.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-13
- Biofrontera Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was -$44.00K.
- Biofrontera Inc. fair value adjustment of warrants for the quarter ending 2026-03-31 was $219.00K.
- Biofrontera Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$482.00K.
- Biofrontera Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $285.00K, a 58.09% decline year-over-year.
- Biofrontera Inc. fair value adjustment of warrants for fiscal 2025 was -$899.00K.
- Biofrontera Inc. fair value adjustment of warrants for fiscal 2024 was -$1.68M.
- Biofrontera Inc. fair value adjustment of warrants for fiscal 2023 was -$6.46M.
- Biofrontera Inc. fair value adjustment of warrants for fiscal 2022 was -$19.02M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$44.00K 10-Q · filed 2026-08-13 | $175.00K 10-Q · filed 2026-08-13 | -$307.00K derived: sum of 3 quarters · filed 2026-08-13 | -$22.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $219.00K 10-Q · filed 2026-05-14 | -$263.00K derived: sum of 2 quarters · filed 2026-05-14 | $22.00K derived: sum of 3 quarters · filed 2026-05-14 | -$131.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -$482.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$197.00K derived: sum of 2 quarters · filed 2026-03-19 | -$350.00K derived: sum of 3 quarters · filed 2026-08-13 | -$899.00K 10-K · filed 2026-03-19 | |||
| 2025-09-30 | $285.00K 10-Q · filed 2025-11-12 | $132.00K derived: sum of 2 quarters · filed 2026-08-13 | -$417.00K 10-Q · filed 2025-11-12 | -$767.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | -$153.00K 10-Q · filed 2026-08-13 | -$702.00K 10-Q · filed 2026-08-13 | -$1.05M derived: sum of 3 quarters · filed 2026-08-13 | -$372.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | -$548.00K 10-Q · filed 2026-05-14 | -$899.00K derived: sum of 2 quarters · filed 2026-05-14 | -$219.00K derived: sum of 3 quarters · filed 2026-05-14 | -$5.66M derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | -$351.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $329.00K derived: sum of 2 quarters · filed 2026-03-19 | -$5.11M derived: sum of 3 quarters · filed 2026-03-19 | -$1.68M 10-K · filed 2026-03-19 | |||
| 2024-09-30 | $680.00K 10-Q · filed 2025-11-12 | -$4.76M derived: sum of 2 quarters · filed 2025-11-12 | -$1.33M 10-Q · filed 2025-11-12 | -$5.78M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | -$5.44M 10-Q · filed 2025-08-13 | -$2.01M 10-Q · filed 2025-08-13 | -$6.46M derived: sum of 3 quarters · filed 2025-08-13 | -$7.06M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | $3.43M 10-Q · filed 2025-05-15 | -$1.03M derived: sum of 2 quarters · filed 2025-05-15 | -$1.62M derived: sum of 3 quarters · filed 2025-05-15 | -$2.00M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$4.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$5.05M derived: sum of 2 quarters · filed 2025-03-20 | -$5.43M derived: sum of 3 quarters · filed 2025-03-20 | -$6.46M 10-K · filed 2025-03-20 | |||
| 2023-09-30 | -$598.00K 10-Q · filed 2024-11-14 | -$973.00K derived: sum of 2 quarters · filed 2024-11-14 | -$2.00M 10-Q · filed 2024-11-14 | -$3.12M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | -$375.00K 10-Q · filed 2024-08-14 | -$1.40M 10-Q · filed 2024-08-14 | -$2.52M derived: sum of 3 quarters · filed 2024-08-14 | -$6.34M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$1.03M 10-Q · filed 2024-05-15 | -$2.15M derived: sum of 2 quarters · filed 2024-05-15 | -$5.96M derived: sum of 3 quarters · filed 2024-05-15 | -$11.33M derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$4.93M derived: sum of 2 quarters · filed 2024-03-15 | -$10.31M derived: sum of 3 quarters · filed 2024-03-15 | -$19.02M 10-K · filed 2024-03-15 | -$16.39M 10-K · filed 2023-03-13 | ||
| 2022-09-30 | -$3.81M 10-Q · filed 2023-11-09 | -$1.19M 10-Q · filed 2022-11-14 | -$9.19M derived: sum of 2 quarters · filed 2023-11-09 | -$17.90M 10-Q · filed 2023-11-09 | -$15.27M 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | -$5.37M 10-Q · filed 2023-08-11 | -$14.08M 10-Q · filed 2023-08-11 | |||||
| 2022-03-31 | -$8.71M 10-Q · filed 2023-05-12 | ||||||
| 2021-12-31 | $12.80M 8-K · filed 2023-10-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |